15 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27774128	38	Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead.	Ono Pharmaceutical
25746814	80	Discovery of novel S1P2 antagonists. Part 1: discovery of 1,3-bis(aryloxy)benzene derivatives.	Ono Pharmaceutical
25100502	15	Design and synthesis of sulfamoyl benzoic acid analogues with subnanomolar agonist activity specific to the LPA2 receptor.	The University of Tennessee Health Science Center
23395664	66	Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.	The University of Utah
22801643	6	Selective non-lipid modulator of LPA5 activity in human platelets.	Sanofi-Aventis Deutschland
18178086	26	Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents.	Amgen
17379528	30	Synthesis and SAR studies of a novel class of S1P1 receptor antagonists.	Sankyo
19800804	19	Structure-based drug design identifies novel LPA3 antagonists.	The University of Memphis
18467108	26	Identification of non-lipid LPA3 antagonists by virtual screening.	The University of Memphis
16913720	15	Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.	The University of Utah
16290140	54	Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.	University of Tennessee Health Science Center
16263282	43	Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.	University of Tennessee Health Science Center
16033271	81	Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.	University of Tennessee Health Science Center
15177461	140	Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists.	Merck Research Laboratories
15177455	27	Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid.	Oxford University